Related Experiment Video

Updated: Aug 19, 2026

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers
10:49

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers

Published on: September 26, 2019

Cutting edge: p27Kip1 deficiency reduces the requirement for CD28-mediated costimulation in naive CD8+ but not CD4+ T

Lawrence A Wolfraim1, John J Letterio

  • 1Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. wolfraim@tolergenics.com

Journal of Immunology (Baltimore, Md. : 1950)
|February 25, 2005
PubMed

Insights

p27(Kip1) deficiency impacts naive CD8(+) T cell expansion more than CD4(+) T cells. This occurs because CD8(+) T cells require less CD28 costimulation when p27(Kip1) is absent, revealing a key difference in cell cycle regulation.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • T cell activation and proliferation are tightly regulated processes.
  • Cyclin-dependent kinase 2 (CDK2) is crucial for cell cycle re-entry in quiescent T cells.
  • p27(Kip1) is considered a primary inhibitor of CDK2, restricting T cell S-phase entry.

Purpose of the Study:

  • To investigate the role of p27(Kip1) in regulating T cell expansion, particularly the differences between CD8(+) and CD4(+) T cell subsets.
  • To elucidate the impact of p27(Kip1) deficiency on T cell proliferation and its relationship with CD28 costimulation.

Main Methods:

  • Analysis of murine naive CD8(+) and CD4(+) T cell expansion in the absence of p27(Kip1).
  • Assessment of the requirement for CD28-mediated costimulation in p27(Kip1)-deficient T cells.
  • Comparison of cell cycle regulation mechanisms between CD8(+) and CD4(+) T cell subsets.

Main Results:

  • p27(Kip1) deficiency significantly enhanced the expansion of naive CD8(+) T cells compared to CD4(+) T cells.
  • CD8(+) T cells lacking p27(Kip1) exhibited a reduced dependency on CD28-mediated costimulation for proliferation.
  • CD4(+) T cells lacking p27(Kip1) still showed a significant requirement for CD28 costimulation.

Conclusions:

  • p27(Kip1) plays a differential role in regulating the expansion of CD8(+) versus CD4(+) T cells.
  • The coupling of CD28 signaling to the cell cycle machinery differs between CD8(+) and CD4(+) T cell subsets.
  • These findings reveal a previously unrecognized mechanism controlling T cell subset proliferation and activation.

More Related Videos

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...